Year of birth: 1985
Anders Hedlund is CEO of Nolsterby Invest AB since 2021, a family office investing in the life science sector. Anders brings more than ten years of finance and investment banking experience in the life science sector. Between 2017 and 2021, Anders worked as an equity analyst at Redeye AB, covering companies predominantly within biotech and medtech. Before that, he had various finance positions in the GE Healthcare group. He has a master’s degree in business economics from Uppsala University.
Independence: Dependent of the Company and the Executive Management and independent of major shareholders.
Other Board Assignments: CEO of Nolsterby Invest AB.
Holdings: 11 598 502 shares (indirect). All shares are owned by Nolsterby Invest AB, which is co-owned by Anders Hedlund to 10%.